SeQuent Scientific acquires Brazil-based animal drug firm for $5 million

On December 16, SeQuent announced it had inked a definitive pact for the acquisition, as a part of the platform’s advanced strategy to boost Alivira’s footprint in Brazil’s pet market. Brazil has the world’s fourth largest pet market with an estimated market size of BRL 1.8 billion, growing annually at 16%.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mdpMR78
via IFTTT